InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Daniel Barber. Director active across 1 company, notably Aquestive Therapeutics, Inc.. Aggregated, 1 reports have been published. Activity tracked since 15 June 2026. The latest transaction was filed on 15 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration